The enhanced biliary secretion of a taurine conjugate in the rat after intraduodenal administration of high doses of fenclozic acid.

1. The metabolic fate of [14C]fenclozic acid (ICI 54450) in rat was determined after intraduodenal administration at different doses. 2. Increasing the dose from 2 to 100 mg/kg resulted in a five-fold increase in drug-related material secreted in bile. 3. At a dose of 2 mg/kg the taurine conjugate was a relatively minor metabolite, whereas at 100 mg/kg this conjugate was the major metabolite in bile and urine. 4. Enhanced biliary secretion of the taurine conjugate in rats receiving multiple doses of fenclozic acid results in exposure of the intestinal cells to much greater concn. of drug-related metabolites.

[1]  B. Newbould,et al.  CHEMOTHERAPY OF ARTHRITIS INDUCED IN RATS BY MYCOBACTERIAL ADJUVANT. , 1963, British journal of pharmacology and chemotherapy.

[2]  J. Caldwell,et al.  Metabolism of arylacetic acids. 1. The fate of 1-naphthylacetic acid and its variation with species and dose. , 1977, Xenobiotica; the fate of foreign compounds in biological systems.

[3]  J. Weisburger,et al.  Participation of liver fractions and of intestinal bacteria in the metabolism of N-hydroxy-N-2-fluorenylacetamide in the rat. , 1970, Biochemical pharmacology.

[4]  J. Caldwell,et al.  Studies on the metabolism of arylacetic acids. 5. The metabolic fate of 2-naphthylacetic acid in the rat, rabbit and ferret. , 1978, Xenobiotica; the fate of foreign compounds in biological systems.

[5]  D. Foulkes.  The metabolism of C14-ICI 54,450 (myalex) in various species--an in vivo NIH shift. , 1970, The Journal of pharmacology and experimental therapeutics.

[6]  K C Kwan,et al.  Enterohepatic circulation of indomethacin and its role in intestinal irritation. , 1975, Biochemical pharmacology.

[7]  G. E. Dagle,et al.  Indomethacin-induced intestinal lesions in the rat. , 1970, Toxicology and applied pharmacology.

[8]  D. S. Platt.  Pharmacokinetics of fenclozic acid in animals and man. , 1971, Journal of pharmaceutical sciences.

[9]  A. Bruusgaard.  Quantitative determination of the major 3-hydroxy bile acids in biological material after thin-layer chromatographic separation. , 1970, Clinica chimica acta; international journal of clinical chemistry.

[10]  R. T. Williams,et al.  The structure of the glucuronide of sulphadimethoxine formed in man. , 1965, The Biochemical journal.

[11]  F. Barbier,et al.  Separation of conjugated and unconjugated bile acids by thin-layer chromatography. , 1976, Clinica chimica acta; international journal of clinical chemistry.

[12]  C. Irving,et al.  Biliary excretion of the O-glucuronide of N-hydroxy-2-acetylamino-fluorene by the rat and rabbit. , 1967, Cancer research.

[13]  R. T. Williams,et al.  Biliary excretion of foreign compounds. Biphenyl, stilboestrol and phenolphthalein in the rat: molecular weight, polarity and metabolism as factors in biliary excretion. , 1967, The Biochemical journal.

[14]  K. S. Dodgson,et al.  Detoxication of sodium 35S-sulphide in the rat , 1972 .

[15]  D. Shriver.  A profile of the rat gastrointestinal toxicity of drugs used to treat inflammatory diseases , 1975 .

[16]  G. J. Stacey,et al.  2-(4-chlorophenyl)thiazol-4-ylacetic Acid (‘Myalex’): a New Compound with Anti-inflammatory, Analgesic and Antipyretic Activity , 1969, Nature.

[17]  B. Newbould.  The pharmacology of fenclozic acid (2‐(4‐chlorophenyl)‐thiazol‐4‐ylacetic acid; I.C.I. 54, 450; ‘Myalex’); a new compound with anti‐inflammatory, analgesic and antipyretic activity , 1969, British journal of pharmacology.

[18]  D. C. Roberts,et al.  The Carcinogenic Action of 4-Aminodiphenyl and 3:2'-Dimethyl-4-Aminodiphenyl , 1952, British journal of industrial medicine.

[19]  F. Barbier,et al.  Stereospecific distribution of fatty acids in human plasma triglycerides. , 1976, Clinica chimica acta; international journal of clinical chemistry.

[20]  M. James,et al.  The conjugation of phenylacetic acid in man, sub-human primates and some non-primate species , 1972, Proceedings of the Royal Society of London. Series B. Biological Sciences.